ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.358,98
-0,25%
S&P 500
5.482,59
0,94%
US Dollar vs BRL
5,4235
1,21%
Bitcoin
66.975,28
0,50%
Brent Oil
83,91
2,17%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Pardes Biosciences Inc (PRDS)

  7. Pardes Biosciences Inc (PRDS) Notícias

PRDS

Pardes Biosciences (PRDS)

Pardes Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRDS
DataHoraFonteTítuloCódigoCompanhia
11/09/202309:00Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:PRDSPardes Biosciences Inc
31/08/202318:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRDSPardes Biosciences Inc
31/08/202315:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRDSPardes Biosciences Inc
31/08/202310:06Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:PRDSPardes Biosciences Inc
31/08/202310:03Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:PRDSPardes Biosciences Inc
31/08/202309:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRDSPardes Biosciences Inc
31/08/202309:53Edgar (US Regulatory)Form SC TO-T/A - Tender offer statement by Third Party: [Amend]NASDAQ:PRDSPardes Biosciences Inc
31/08/202309:34Edgar (US Regulatory)Form SC 13E3/A - Going private transaction by certain issuers: [Amend]NASDAQ:PRDSPardes Biosciences Inc
31/08/202309:30Edgar (US Regulatory)Form SC 14D9/A - Solicitation, recommendation statements: [Amend]NASDAQ:PRDSPardes Biosciences Inc
31/08/202309:15GlobeNewswire Inc.Pardes Biosciences Announces Closing of Tender OfferNASDAQ:PRDSPardes Biosciences Inc
28/08/202312:33Business WireMediPacific Offering $2.13 Per Share Plus One Contingent Value Right Per Share in Tender Offer for Pardes BiosciencesNASDAQ:PRDSPardes Biosciences Inc
17/08/202318:43Business WireMediPacific Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Pardes Biosciences SharesNASDAQ:PRDSPardes Biosciences Inc
04/08/202317:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRDSPardes Biosciences Inc
28/07/202318:08Edgar (US Regulatory)Form SC 13E3 - Going private transaction by certain issuersNASDAQ:PRDSPardes Biosciences Inc
28/07/202318:04Edgar (US Regulatory)Form SC 14D9 - Solicitation, recommendation statementsNASDAQ:PRDSPardes Biosciences Inc
28/07/202318:01Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNASDAQ:PRDSPardes Biosciences Inc
17/07/202308:58Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:PRDSPardes Biosciences Inc
17/07/202308:11Edgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:PRDSPardes Biosciences Inc
17/07/202308:00GlobeNewswire Inc.Pardes Biosciences Enters into Agreement to be Acquired by MediPacific, Inc. for between $2.02 and $2.19 in Cash per Share Plus Contingent Value RightsNASDAQ:PRDSPardes Biosciences Inc
05/06/202317:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PRDSPardes Biosciences Inc
02/06/202317:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PRDSPardes Biosciences Inc
05/05/202317:06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PRDSPardes Biosciences Inc
05/05/202317:01GlobeNewswire Inc.Pardes Biosciences Reports First Quarter 2023 Financial ResultsNASDAQ:PRDSPardes Biosciences Inc
21/04/202317:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRDSPardes Biosciences Inc
20/04/202308:54Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PRDSPardes Biosciences Inc
20/04/202308:50Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PRDSPardes Biosciences Inc
03/04/202309:00GlobeNewswire Inc.Pardes Biosciences Announces Top-line Results from Phase 2 Trial Evaluating Pomotrelvir for the Treatment of COVID-19NASDAQ:PRDSPardes Biosciences Inc
14/03/202317:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PRDSPardes Biosciences Inc
14/03/202317:01GlobeNewswire Inc.Pardes Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business UpdateNASDAQ:PRDSPardes Biosciences Inc
14/02/202319:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRDSPardes Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PRDS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
OIBR3
OI ON
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
AZEV4
AZEVEDO PN
BOV
HBOR3
HELBOR ON
BOV
TELB4
TELEBRAS PN
BOV
HOOT4
HOTEIS OTHON PN
BOV
JHSF3
JHSF PART ON
BOV
DASA3
DASA ON
BOV
VVEO3
CM Hospitalar ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
CLSA3
Clear Sale ON
BOV
TECN3
TECHNOS ON
BOV
PFRM3
PROFARMA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados